HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Anti-Aging Trend Could Slow As “Beauty Ideal” Changes – Forecaster

This article was originally published in The Rose Sheet

Executive Summary

Industry forecaster Antoinette van den Berg suggests that the anti-aging trend may slow in the next 10 years as consumers embrace natural aging. “Old is going to be cool,” she said during a presentation at the recent in-cosmetics conference in Barcelona.

You may also be interested in...



Care2 Petitions Top Beauty Firms To Call 'Anti-Aging' Products … Something Else

An online petition launched through B Corp social network Care2 urges Estee Lauder and L’Oreal to remove the term “anti-aging” from their products and marketing in favor or more age-positive language. The appeal follows beauty magazine Allure’s recent commitment to stop using the term, which it says negatively suggests “that aging is a condition we need to battle.”

Men Can Be Reached With “Right” Language – King Of Shaves Founder

Contrary to the hype, the men’s market is growing at only a “very average” rate, The King of Shaves founder Will King says. There is potential for an “awakening,” however, with the right message, the exec suggests.

Valisure’s Benzene Testing Challenged By PCPC; FDA Focus Should Be Raw Materials, Trade Group Says

On roughly the 1-year anniversary of Valisure’s citizen petition to the FDA regarding benzene detected in body sprays, the Personal Care Products Council weighs in on the matter.

Latest News
See All
UsernamePublicRestriction

Register

RS018112

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel